Maternal Mental Health Awareness Week: May 1-7, 2023
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
TMS in pregnancy and the postpartum period appears to be a promising treatment option with no reports of adverse obstetric outcomes or congenital malformations.
There is evidence that depression itself can increase risk for hypertension and preeclampsia. Future studies will help to clarify the complex interaction between depression, SSRI treatment and pre-eclampsia.
Last month, the Alliance for Innovation on Maternal Health (AIM) launched a new Patient Safety Bundle addressing perinatal mental health conditions. The current revision addresses gaps in the safety bundle previously released in 2016. Patient [...]
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children.
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.
Data from a Nordic register-based study observed a significant increase in risk for autism spectrum disorder and intellectual disability in children with prenatal exposure to topiramate.